PROTALIX BIOTHERAPEUTICS INC

Ticker: PLX CUSIP: 74365A309 Class: Common Stock

CAPITAL PERFORMANCE ADVISORS LLP's Holding History (CIK: 0001905663)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 25,975 Value ($000) $47 Avg Close $2.04 Range $1.60 - $2.66
Q3 2025
Shares 25,975 Value ($000) $58 Avg Close $1.63 Range $1.36 - $2.26
Q2 2025
Shares 25,976 Value ($000) $38 Avg Close $2.05 Range $1.32 - $3.10
Q1 2025
Shares 25,976 Value ($000) $66 Avg Close $2.39 Range $1.86 - $2.76
Q4 2024
Shares 25,976 Value ($000) $49 Avg Close $1.41 Range $0.99 - $1.96
Q3 2024
Shares 25,976 Value ($000) $26 Avg Close $1.05 Range $0.82 - $1.22
Q2 2024
Shares 26,793 Value ($000) $31 Avg Close $1.18 Range $1.03 - $1.37
Q1 2024
Shares 26,258 Value ($000) $33 Avg Close $1.49 Range $1.21 - $1.85
Q4 2023
Shares 25,975 Value ($000) $46 Avg Close $1.56 Range $1.21 - $1.90
Q3 2023
Shares 25,974 Value ($000) $43 Avg Close $1.79 Range $1.43 - $2.09
Q2 2023
Shares 25,974 Value ($000) $52 Avg Close $2.38 Range $1.90 - $3.55
Q1 2023
Shares 25,974 Value ($000) $55 Avg Close $1.75 Range $1.32 - $2.21
Q4 2022
Shares 25,974 Value ($000) $36 Avg Close $1.10 Range $1.00 - $1.38
Q3 2022
Shares 25,974 Value ($000) $27 Avg Close $1.11 Range $1.02 - $1.26
Q2 2022
Shares 25,974 Value ($000) $28 Avg Close $1.17 Range $0.98 - $2.00